C3 Ceramide-d5
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
C3 Ceramide-d5 Product Information
C3 Ceramide-d5 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-98618.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
C3 Ceramide-d5
CAT No.
CS-T-98618
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C21H36D5NO3
Molecular Weight
360.59
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
C3 Ceramide-d5 is supplied with detailed characterization data compliant with regulatory guideline. C3 Ceramide-d5 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Isotope labelled C3 Ceramide is a biologically active, cell permeable, but nonphysiologic ceramide analog. C3 Ceramide was found to exhibit antitumor activities by inducing differentiation of human HL-60 leukemia cells. C3 Ceramide is considered a potential differentiation-inducing therapy for treatment of cancer including acute myeloid leukemia."
Synonyms
C3 Ceramide-d5
Application Notes
"Isotope labelled C3 Ceramide is a biologically active, cell permeable, but nonphysiologic ceramide analog. C3 Ceramide was found to exhibit antitumor activities by inducing differentiation of human HL-60 leukemia cells. C3 Ceramide is considered a potential differentiation-inducing therapy for treatment of cancer including acute myeloid leukemia."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.